We are also active in more general science policy issues and work closely with other learned societies. Recent activities, in conjunction with the Society of Biology, include:
• Reacting to, and providing guidance on, the recent policy changes regarding the dissemination and communication of research, including open access.
• Core membership of the Drug Discovery Pathways Group, established to address the changing landscape of the pharmaceutical industry in the UK.
• Working to assess and monitor the importance of scientific research and development and its benefit to the UK economy.